Treatment of early immunoglobulin A nephropathy by angiotensin-converting enzyme inhibitor

American Journal of Medicine

Volumn 126, Issue 2, 2013, Pages 162-168

  Li, Philip Kam Tao ^a   Kwan, Bonnie Ching Ha ^a   Chow, Kai Ming ^a   Leung, Chi Bon ^a   Szeto, Cheuk Chun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chronic kidney disease; Proteinuria; Renin angiotensin system

Indexed keywords

IMMUNOGLOBULIN A; RAMIPRIL;

ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; COUGHING; DIZZINESS; DRUG TOLERABILITY; DRUG WITHDRAWAL; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROTEINURIA; RAMIPRIL;

EID: 84872550206     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.06.028     Document Type: Article

References (18)

1. G. D'Amico The commonest glomerulonephritis in the world: IgA nephropathy Q J Med 245 1987 709 727
2. G. D'Amico Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors Am J Kidney Dis 36 2000 227 237
3. P.K. Li, K.K. Ho, C.C. Szeto, L.M. Yu, F.M. Lai Prognostic indicators of IgA nephropathy in Chinese - clinical and pathological perspectives Nephrol Dial Transplant 17 2002 64 69
4. M. Haas Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases Am J Kidney Dis 29 1997 829 842
5. J.H. Galla IgA nephropathy Kidney Int 47 1995 377 387
6. G. D'Amico, A. Ragni, E. Gandini, G. Fellin Typical and atypical natural history of IgA nephropathy Contrib Nephrol 104 1993 6 13
7. C.C. Szeto, F.M. Lai, K.F. To The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria Am J Med 110 2001 434 437
8. G. Maschio, L. Cagnoli, F. Claroni ACE inhibition reduce proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study Nephrol Dial Transplant 9 1994 265 269
9. D. Russo, A. Pisani, M.M. Balletta Additive anti-proteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy Am J Kidney Dis 33 1999 851 856
10. N. Perico, A. Remuzzi, F. Sangalli The antiproteinuria effect of angiotensin antagonsim in human IgA nephropathy is potentiated by indomethacin J Am Soc Nephrol 9 1998 2308 2317
11. P. Ruggenenti, A. Perna, G. Gherardi, R. Benini, G. Remuzzi Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury Am J Kidney Dis 35 2000 1155 1165
12. P. Ruggenenti, A. Perna, G. Gherardi, F. Gaspari, R. Benini, G. Remuzzi Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy Lancet 352 1998 1252 1256
13. P. Ruggenenti, A. Perna, G. Gherardi Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria Lancet 354 1999 359 364
14. K.F. To, P.C. Choi, C.C. Szeto Outcome of IgA nephropathy in adults graded by chronic histological lesions Am J Kidney Dis 35 2000 392 400
15. Y.C. Ma, L. Zuo, J.H. Chen Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease J Am Soc Nephrol 17 2006 2937 2944
16. L.Y. Agodoa, L. Appel, G.L. Bakris Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial JAMA 285 2001 2719 2728
17. Kidney Disease Improving Global Outcomes (KDIGO). Clinical practice guideline for glomerulonephritis Kidney Int 2 Suppl 2 2012 209 217
18. P.K. Li, C.B. Leung, K.M. Chow Hong Kong study using Valsartan in IgA Nephropathy (HKVIN) - a double-blind randomized placebo-controlled study Am J Kidney Dis 47 2006 751 760